Study reveals dopamine’s role in reducing the value of reward memories

New research out of Michigan State University expands on current understanding of the brain chemical dopamine, finding that it plays a role in reducing the value of memories associated with rewards.

AusperBio’s AHB-137 breakthrough designation in China for CHB

AHB-137 is a new therapeutic option for patients with chronic hepatitis B. Credit: Peakstock/Shutterstock. AusperBio Therapeutics and Ausper Biopharma have gained breakthrough therapy designation (BTD)

July 11, 2024

Pitt secures $7.8 million grant to improve quality of care for patients with opioid use disorder

The University of Pittsburgh School of Pharmacy’s Program Evaluation and Research Unit (PERU) has received a five-year, $7.8 million grant from the National Institute on

January 30, 2024

Cord blood banking industry faces scrutiny over unproven claims and high costs

Some private UK biobanks may be misleading expectant parents about the value of storing umbilical cord blood to treat life-threatening diseases that may arise in

July 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.